English

• 

• 1. [1] CHEN Wanqing,ZHANG Siwei,ZENG Hongmei,et al.Report of Cancer Incidence and Mortality in China 2010[J].China Cancer,2014,23(1):1-10(in Chinese).陈万青,张思维,曾红梅,等.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10.[1] CHEN Wanqing,ZHANG Siwei,ZENG Hongmei,et al.Report of Cancer Incidence and Mortality in China 2010[J].China Cancer,2014,23(1):1-10(in Chinese).陈万青,张思维,曾红梅,等.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10.

  2. [2] CHEN Jianguo.Trends in the Incidence of Liver Cancer and Its Primary Prevention in China[J].J Clin Hepatol,2012,28(4):256-260(in Chinese).陈建国.中国肝癌发病趋势和一级预防[J].临床肝胆病杂志,2012,28(4):256-260.[2] CHEN Jianguo.Trends in the Incidence of Liver Cancer and Its Primary Prevention in China[J].J Clin Hepatol,2012,28(4):256-260(in Chinese).陈建国.中国肝癌发病趋势和一级预防[J].临床肝胆病杂志,2012,28(4):256-260.

  3. [3] Ueno M,Uchiyama K,Ozawa S,et al.Adjuvant Chemolipiodolization Reduces Early Recurrence Derived from Intrahepatic Metastasis of Hepatocellular Carcinoma after Hepatectomy[J].Ann Surg Oncol,2011,18(13):3624-3631.[3] Ueno M,Uchiyama K,Ozawa S,et al.Adjuvant Chemolipiodolization Reduces Early Recurrence Derived from Intrahepatic Metastasis of Hepatocellular Carcinoma after Hepatectomy[J].Ann Surg Oncol,2011,18(13):3624-3631.

  4. [4] WANG Fang,FU Liwu.Research Advances in Sorafenib:A Multiple Targeted Anti-tumor Agent[J].Chinese Pharmacol Bull,2008,24(8):1117-1120(in Chinese).王芳,符立梧.多靶点抗肿瘤新药索拉非尼的研究进展[J].中国药理学通报,2008,24(8):1117-1120.[4] WANG Fang,FU Liwu.Research Advances in Sorafenib:A Multiple Targeted Anti-tumor Agent[J].Chinese Pharmacol Bull,2008,24(8):1117-1120(in Chinese).王芳,符立梧.多靶点抗肿瘤新药索拉非尼的研究进展[J].中国药理学通报,2008,24(8):1117-1120.

  5. [5] Scott W,Christopher C,Mark L,et al.Discovery and Development of Sorafenib:A Multikinase Inhibitor for Treating Cancer[J].Nat Rev Drug Discov,2006,5(10):835-844.[5] Scott W,Christopher C,Mark L,et al.Discovery and Development of Sorafenib:A Multikinase Inhibitor for Treating Cancer[J].Nat Rev Drug Discov,2006,5(10):835-844.

  6. [6] Yang S M,Huang Z N,Zhou Z S,et al.Structure-based Design,Structure-Activity Relationship Analysis,and Antitumor Activity of Diaryl Ether Derivatives[J].Arch Pharm Res,2015,38(10):1761-1773.[6] Yang S M,Huang Z N,Zhou Z S,et al.Structure-based Design,Structure-Activity Relationship Analysis,and Antitumor Activity of Diaryl Ether Derivatives[J].Arch Pharm Res,2015,38(10):1761-1773.

  7. [7] Hou J,Zhao W,Huang Z N,et al.Evaluation of Novel N-(Piperidin-4-yl) benzamide Derivativesas Potential Cell Cycle Inhibitors in HepG2 Cells[J].Chem Biol Drug Des,2015,86(2):223-231.[7] Hou J,Zhao W,Huang Z N,et al.Evaluation of Novel N-(Piperidin-4-yl) benzamide Derivativesas Potential Cell Cycle Inhibitors in HepG2 Cells[J].Chem Biol Drug Des,2015,86(2):223-231.

  8. [8] Lobb K,Hipskind P,Aikins J,et al.Acyl Sulfonamide Anti-Proliferatives:Benzene Substituent Structure-Activity Relationships for a Novel Class of Antitumor Agents[J].J Med Chem,2004,47(22):5367-5380.[8] Lobb K,Hipskind P,Aikins J,et al.Acyl Sulfonamide Anti-Proliferatives:Benzene Substituent Structure-Activity Relationships for a Novel Class of Antitumor Agents[J].J Med Chem,2004,47(22):5367-5380.

  9. [9] Bouchain G,Leit S,Frechette S,et al.Development of Potential Antitumor Agents.Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors[J].J Med Chem,2003,46(5):820-830.[9] Bouchain G,Leit S,Frechette S,et al.Development of Potential Antitumor Agents.Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors[J].J Med Chem,2003,46(5):820-830.

  10. [10] LIU Fei,LIU Nan,HE Ling.Synthesis and Antitumor Activities of Sulfonyl Amidine Derivatives[J].Chinese J Synth Chem,2014,22(4):440-443(in Chinese).刘菲,刘楠,何菱.磺酰脒衍生物的合成及其抗肿瘤活性[J].合成化学,2014,22(4):440-443.[10] LIU Fei,LIU Nan,HE Ling.Synthesis and Antitumor Activities of Sulfonyl Amidine Derivatives[J].Chinese J Synth Chem,2014,22(4):440-443(in Chinese).刘菲,刘楠,何菱.磺酰脒衍生物的合成及其抗肿瘤活性[J].合成化学,2014,22(4):440-443.

  11. [11] Yang Y,Wang Z,Yang J,et al.Design,Synthesis and Evaluation of Novel Molecules with a Diphenyl Ether Nucleus as Potential Antitubercular Agents[J].Bioorg Med Chem Lett,2012,22(2):954-957.[11] Yang Y,Wang Z,Yang J,et al.Design,Synthesis and Evaluation of Novel Molecules with a Diphenyl Ether Nucleus as Potential Antitubercular Agents[J].Bioorg Med Chem Lett,2012,22(2):954-957.

  12. [12] Gamet-Payrastre L,Li P,Lumeau S,et al.Sulforaphane,a Naturally Occurring Isothiocyanate,Induces Cell Cycle Arrest and Apoptosis in HT29 Human Colon Cancer Cells[J].Cancer Res,2000,60(5):1426-1433.[12] Gamet-Payrastre L,Li P,Lumeau S,et al.Sulforaphane,a Naturally Occurring Isothiocyanate,Induces Cell Cycle Arrest and Apoptosis in HT29 Human Colon Cancer Cells[J].Cancer Res,2000,60(5):1426-1433.

•